Ljubljana – Novartis has signed an initial agreement to use its manufacturing facility in Ljubljana to fill the Pfizer-BioNTech vaccine against Covid-19. The Novartis Technical Operations site in Ljubljana will fill at least 24 million doses in its sterile manufacturing facilities in 2022, the Swiss pharma company announced on Thursday. Novartis plans to take bulk mRNA active ingredient from BioNTech and fill it into vials under sterile conditions for shipment back to BioNTech for its distribution. Subject to reaching a final agreement, Novartis plans to start filling and finishing the…
Latest
Most Popular
Slovenia’s Stance on Cryptocurrency and Digital Euro
Today, Slovenia is well-recognized, particularly in Europe as a haven for innovations, technological advancements, and progressive thinking. This environment has enabled Slovenia, one of...
Cryptocurrency Tax in Slovenia
When amateur investors start trading with cryptocurrencies and making profits turns into a business, tax standards come into effect in this area as well.Status...
The Blockchain Industry in Slovenia
Slovenia, though small, is one of the fastest-growing countries in Europe, particularly in the business and economic contexts. After its successful economic succession from...